270 related articles for article (PubMed ID: 22479362)
1. The putative tumor suppressor VILIP-1 counteracts epidermal growth factor-induced epidermal-mesenchymal transition in squamous carcinoma cells.
Schönrath K; Klein-Szanto AJ; Braunewell KH
PLoS One; 2012; 7(3):e33116. PubMed ID: 22479362
[TBL] [Abstract][Full Text] [Related]
2. Involvement of VILIP-1 (visinin-like protein) and opposite roles of cyclic AMP and GMP signaling in in vitro cell migration of murine skin squamous cell carcinoma.
Schönrath K; Pan W; Klein-Szanto AJ; Braunewell KH
Mol Carcinog; 2011 May; 50(5):319-33. PubMed ID: 21480386
[TBL] [Abstract][Full Text] [Related]
3. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells.
Mahloogi H; González-Guerrico AM; Lopez De Cicco R; Bassi DE; Goodrow T; Braunewell KH; Klein-Szanto AJ
Cancer Res; 2003 Aug; 63(16):4997-5004. PubMed ID: 12941826
[TBL] [Abstract][Full Text] [Related]
5. Visinin-like protein-1 is a potent inhibitor of cell adhesion and migration in squamous carcinoma cells.
Gonzalez Guerrico AM; Jaffer ZM; Page RE; Braunewell KH; Chernoff J; Klein-Szanto AJ
Oncogene; 2005 Mar; 24(14):2307-16. PubMed ID: 15735716
[TBL] [Abstract][Full Text] [Related]
6. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug.
Saito D; Kyakumoto S; Chosa N; Ibi M; Takahashi N; Okubo N; Sawada S; Ishisaki A; Kamo M
J Biochem; 2013 Mar; 153(3):303-15. PubMed ID: 23248240
[TBL] [Abstract][Full Text] [Related]
8. DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma.
Higashikawa K; Yoneda S; Tobiume K; Saitoh M; Taki M; Mitani Y; Shigeishi H; Ono S; Kamata N
Int J Cancer; 2009 Jun; 124(12):2837-44. PubMed ID: 19267405
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor Snail expressed in cutaneous squamous cell carcinoma induces epithelial-mesenchymal transition and down-regulates COX-2.
Shimokawa M; Haraguchi M; Kobayashi W; Higashi Y; Matsushita S; Kawai K; Kanekura T; Ozawa M
Biochem Biophys Res Commun; 2013 Jan; 430(3):1078-82. PubMed ID: 23261444
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells.
Vergara D; Valente CM; Tinelli A; Siciliano C; Lorusso V; Acierno R; Giovinazzo G; Santino A; Storelli C; Maffia M
Cancer Lett; 2011 Nov; 310(1):1-8. PubMed ID: 21794976
[TBL] [Abstract][Full Text] [Related]
11. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.
Usami Y; Satake S; Nakayama F; Matsumoto M; Ohnuma K; Komori T; Semba S; Ito A; Yokozaki H
J Pathol; 2008 Jul; 215(3):330-9. PubMed ID: 18491351
[TBL] [Abstract][Full Text] [Related]
12. Correlation of visinin-like-protein-1 expression with clinicopathological features in squamous cell carcinoma of the esophagus.
Wickborn C; Klein-Szanto AJ; Schlag PM; Braunewell KH
Mol Carcinog; 2006 Aug; 45(8):572-81. PubMed ID: 16683251
[TBL] [Abstract][Full Text] [Related]
13. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas.
Yokoyama K; Kamata N; Fujimoto R; Tsutsumi S; Tomonari M; Taki M; Hosokawa H; Nagayama M
Int J Oncol; 2003 Apr; 22(4):891-8. PubMed ID: 12632084
[TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
15. VILIP-1 expression in vivo results in decreased mouse skin keratinocyte proliferation and tumor development.
Fu J; Jin F; Zhang J; Fong K; Bassi DE; Lopez De Cicco R; Ramaraju D; Braunewell KH; Conti C; Benavides F; Klein-Szanto AJ
PLoS One; 2010 Apr; 5(4):e10196. PubMed ID: 20419170
[TBL] [Abstract][Full Text] [Related]
16. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells.
Liu ZC; Chen XH; Song HX; Wang HS; Zhang G; Wang H; Chen DY; Fang R; Liu H; Cai SH; Du J
Cell Tissue Res; 2014 Nov; 358(2):491-502. PubMed ID: 25124796
[TBL] [Abstract][Full Text] [Related]
17. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
[TBL] [Abstract][Full Text] [Related]
18. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.
Dang H; Ding W; Emerson D; Rountree CB
BMC Cancer; 2011 Sep; 11():396. PubMed ID: 21929801
[TBL] [Abstract][Full Text] [Related]
19. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
[TBL] [Abstract][Full Text] [Related]
20. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
